Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.

Benn P, Norwitz ER, Pergament E.

Am J Obstet Gynecol. 2016 Aug;215(2):252-3. doi: 10.1016/j.ajog.2016.04.012. Epub 2016 Apr 16. No abstract available.

PMID:
27091082
2.

The promise of gene therapy.

Pergament E.

Curr Opin Obstet Gynecol. 2016 Apr;28(2):132-5. doi: 10.1097/GCO.0000000000000255.

PMID:
26848786
3.

Cell-free DNA screening for fetal aneuploidy as a clinical service.

Cuckle H, Benn P, Pergament E.

Clin Biochem. 2015 Oct;48(15):932-41. doi: 10.1016/j.clinbiochem.2015.02.011. Epub 2015 Feb 27. Review.

PMID:
25732593
5.

Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.

Pergament E, Cuckle H, Zimmermann B, Banjevic M, Sigurjonsson S, Ryan A, Hall MP, Dodd M, Lacroute P, Stosic M, Chopra N, Hunkapiller N, Prosen DE, McAdoo S, Demko Z, Siddiqui A, Hill M, Rabinowitz M.

Obstet Gynecol. 2014 Aug;124(2 Pt 1):210-8. doi: 10.1097/AOG.0000000000000363.

6.

Replacing the combined test by cell-free DNA testing in screening for trisomies 21, 18 and 13: impact on the diagnosis of other chromosomal abnormalities.

Syngelaki A, Pergament E, Homfray T, Akolekar R, Nicolaides KH.

Fetal Diagn Ther. 2014;35(3):174-84. doi: 10.1159/000358388. Epub 2014 Feb 8.

PMID:
24525399
7.

The Future of Prenatal Diagnosis and Screening.

Pergament E.

J Clin Med. 2014 Nov 14;3(4):1291-301. doi: 10.3390/jcm3041291.

8.

Paternity balancing.

Evans MI, Andriole S, Pergament E, Speer J, Curtis J, Britt DW.

Fetal Diagn Ther. 2013;34(3):135-9. doi: 10.1159/000351857. Epub 2013 Aug 30.

9.

Detection of genetic abnormalities by using CVS and FISH prior to fetal reduction in sonographically normal appearing fetuses.

Rosner M, Pergament E, Andriole S, Gebb J, Dar P, Evans MI.

Prenat Diagn. 2013 Oct;33(10):940-4. doi: 10.1002/pd.4213. Epub 2013 Aug 29.

PMID:
23939830
10.

Response to "half of first trimester screen positive pregnancies with an abnormal karyotype had a normal nuchal translucency measurement".

Alamillo C, Krantz D, Evans M, Fiddler M, Pergament E.

Prenat Diagn. 2013 Aug;33(8):811. doi: 10.1002/pd.4187. No abstract available.

PMID:
23913786
11.

Clinical utility and cost of non-invasive prenatal testing.

Cuckle H, Benn P, Pergament E.

J Matern Fetal Neonatal Med. 2014 Feb;27(3):320-1. doi: 10.3109/14767058.2013.807239. Epub 2013 Jul 30. No abstract available.

PMID:
23875873
12.

Maternal cfDNA screening for Down syndrome--a cost sensitivity analysis.

Cuckle H, Benn P, Pergament E.

Prenat Diagn. 2013 Jul;33(7):636-42. doi: 10.1002/pd.4157. Epub 2013 Jun 9.

PMID:
23674341
13.

Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center.

Alamillo CM, Krantz D, Evans M, Fiddler M, Pergament E.

Prenat Diagn. 2013 Mar;33(3):251-6. doi: 10.1002/pd.4054. Epub 2013 Jan 27.

PMID:
23354915
14.

Reproductive decisions after fetal genetic counselling.

Pergament E, Pergament D.

Best Pract Res Clin Obstet Gynaecol. 2012 Oct;26(5):517-29. doi: 10.1016/j.bpobgyn.2012.04.001. Epub 2012 Jul 17.

PMID:
22809468
15.

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Benn P, Cuckle H, Pergament E.

Obstet Gynecol. 2012 Jun;119(6):1270; author reply 1270-1. doi: 10.1097/AOG.0b013e318258c401. No abstract available.

PMID:
22617594
16.

Digital PCR for noninvasive detection of aneuploidy: power analysis equations for feasibility.

Evans MI, Wright DA, Pergament E, Cuckle HS, Nicolaides KH.

Fetal Diagn Ther. 2012;31(4):244-7. doi: 10.1159/000337544. Epub 2012 Apr 25.

PMID:
22538702
17.

Increased nuchal translucency in the presence of normal chromosomes: what's next?

Alamillo CM, Fiddler M, Pergament E.

Curr Opin Obstet Gynecol. 2012 Mar;24(2):102-8. doi: 10.1097/GCO.0b013e3283505b25. Review.

PMID:
22277886
18.

Genetic assessment following increased nuchal translucency and normal karyotype.

Pergament E, Alamillo C, Sak K, Fiddler M.

Prenat Diagn. 2011 Mar;31(3):307-10. doi: 10.1002/pd.2718. Epub 2011 Feb 15.

PMID:
21321969
19.

First-trimester genetic counseling: perspectives and considerations.

Pergament E.

Clin Lab Med. 2010 Sep;30(3):557-63. doi: 10.1016/j.cll.2010.05.004. Review.

PMID:
20638571
20.

By 2020...

Pergament E.

Prenat Diagn. 2010 Jul;30(7):710-1. doi: 10.1002/pd.2473. No abstract available.

PMID:
20572098

Supplemental Content

Loading ...
Support Center